MD1419G2 - Complecşi de incluziune pe bază de SIN-1A şi ciclodextrină, compoziţii farmaceutice şi truse pe baza lor, procedeu de preparare a complecşilor de incluziune şi metodă de tratament - Google Patents
Complecşi de incluziune pe bază de SIN-1A şi ciclodextrină, compoziţii farmaceutice şi truse pe baza lor, procedeu de preparare a complecşilor de incluziune şi metodă de tratamentInfo
- Publication number
- MD1419G2 MD1419G2 MD95-0440A MD950440A MD1419G2 MD 1419 G2 MD1419 G2 MD 1419G2 MD 950440 A MD950440 A MD 950440A MD 1419 G2 MD1419 G2 MD 1419G2
- Authority
- MD
- Moldova
- Prior art keywords
- sin
- complexes
- cyclodextrin
- base
- kits
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Invenţia se referă la noi complecşi de incluziune, stabili în stare solidă, obţinuţi din forma deschisă a sidnoniminei SIN-1A şi ciclodextrine sau derivaţii lor, care eventual mai conţin ioni, drept catalizatori sau stabilizatori. Complecşii eliberează oxid de azot la temperatura camerei prin dizolvare în apă sau în sisteme apoase.Sunt revendicate de asemenea compoziţii farmaceutice şi truse care conţin aceşti complecşi. Trusele se utilizează ca standarde de eliberare de NO într-o cantitate şi cu un debit previzibil la dizolvare în medii apoase.Invenţia se referă şi la procedeul de preparare a complecşilor prin supunerea SIN-1 acţiunii catalitice a ionilor la un pH potrivit, pentru a deplasa echilibrul spre formarea a SIN-1A în prezenţa moleculelor-gazdă, care este imediat complexat şi stabilizat.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9401183A HU218280B (en) | 1994-04-26 | 1994-04-26 | Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes |
PCT/HU1995/000011 WO1995029172A1 (en) | 1994-04-26 | 1995-04-25 | N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes |
Publications (3)
Publication Number | Publication Date |
---|---|
MD950440A MD950440A (ro) | 1997-10-31 |
MD1419F2 MD1419F2 (ro) | 2000-02-29 |
MD1419G2 true MD1419G2 (ro) | 2000-11-30 |
Family
ID=10985114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MD95-0440A MD1419G2 (ro) | 1994-04-26 | 1995-04-25 | Complecşi de incluziune pe bază de SIN-1A şi ciclodextrină, compoziţii farmaceutice şi truse pe baza lor, procedeu de preparare a complecşilor de incluziune şi metodă de tratament |
Country Status (32)
Country | Link |
---|---|
US (1) | US5698535A (ro) |
EP (1) | EP0705255B1 (ro) |
JP (1) | JP3434828B2 (ro) |
KR (1) | KR960703404A (ro) |
CN (1) | CN1060164C (ro) |
AT (1) | ATE197708T1 (ro) |
AU (1) | AU694219B2 (ro) |
BG (1) | BG61974B1 (ro) |
BR (1) | BR9506155A (ro) |
CA (1) | CA2163539C (ro) |
CZ (1) | CZ316395A3 (ro) |
DE (1) | DE69519463T2 (ro) |
DK (1) | DK0705255T3 (ro) |
ES (1) | ES2153897T3 (ro) |
FI (1) | FI956156A0 (ro) |
GR (1) | GR3035356T3 (ro) |
HR (1) | HRP950249A2 (ro) |
HU (1) | HU218280B (ro) |
IL (1) | IL113491A (ro) |
LT (1) | LT4167B (ro) |
LV (1) | LV11543B (ro) |
MD (1) | MD1419G2 (ro) |
NO (1) | NO311030B1 (ro) |
NZ (1) | NZ285149A (ro) |
PL (1) | PL312183A1 (ro) |
PT (1) | PT705255E (ro) |
RO (1) | RO114449B1 (ro) |
RU (1) | RU2136698C1 (ro) |
SI (1) | SI0705255T1 (ro) |
SK (1) | SK155195A3 (ro) |
WO (1) | WO1995029172A1 (ro) |
YU (1) | YU25995A (ro) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6143746A (en) * | 1994-01-21 | 2000-11-07 | Icos Corporation | Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use |
CA2391008C (en) * | 1999-11-12 | 2009-12-22 | Pitha & Pitha Llc | Crystalline mixtures of partial methyl ethers of beta-cyclodextrin and related compounds |
FR2805462B1 (fr) * | 2000-02-24 | 2003-08-15 | Therabel Res | Nouvelle forme galenique orale a liberation prolongee de la molsidomine |
TWI321054B (en) | 2000-12-19 | 2010-03-01 | California Inst Of Techn | Compositions containing inclusion complexes |
EP1219306A1 (en) * | 2000-12-29 | 2002-07-03 | Nicox S.A. | Compositions comprising cyclodextrins and NO- releasing drugs |
EP2402036B1 (en) | 2002-09-06 | 2018-02-14 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for delivering the therapeutic agents covalently attached thereto |
RU2005114007A (ru) * | 2002-10-09 | 2005-10-10 | Инсерт Терапьютикс, Инк. (Us) | Материалы на основе циклодекстринов, их композиции и применение |
US20080176958A1 (en) | 2007-01-24 | 2008-07-24 | Insert Therapeutics, Inc. | Cyclodextrin-based polymers for therapeutics delivery |
US20110237540A1 (en) * | 2009-11-23 | 2011-09-29 | Crawford Thomas C | Cyclodextrin-based polymers for therapeutic delivery |
WO2014055493A1 (en) | 2012-10-02 | 2014-04-10 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
CA3078625C (en) | 2017-10-09 | 2023-01-17 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
CA3130668A1 (en) | 2019-03-14 | 2020-12-03 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
CN116249522A (zh) * | 2020-07-20 | 2023-06-09 | 深圳迈瑞生物医疗电子股份有限公司 | 一种组合物的血小板解聚用途、解聚试剂及解聚方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991014681A1 (en) * | 1990-03-28 | 1991-10-03 | Chinoin Gyógyszer És Vegyészeti Termékek Gyára Rt | Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5039705A (en) * | 1989-09-15 | 1991-08-13 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
US5208233A (en) * | 1989-09-15 | 1993-05-04 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
US5212204A (en) * | 1989-10-18 | 1993-05-18 | The United States Of America As Represented By The Department Of Health And Human Services | Antihypertensive compositions and use thereof |
JP3190340B2 (ja) * | 1991-09-24 | 2001-07-23 | アメリカ合衆国 | 酸化窒素供与体プロドラッグとしての求核試薬−酸化窒素付加物の酸素置換誘導体 |
US5389675A (en) * | 1992-03-27 | 1995-02-14 | The United States Of America As Represented By The Department Of Health And Human Services | Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents |
-
1994
- 1994-04-26 HU HU9401183A patent/HU218280B/hu not_active IP Right Cessation
-
1995
- 1995-04-25 ES ES95918104T patent/ES2153897T3/es not_active Expired - Lifetime
- 1995-04-25 RO RO95-02248A patent/RO114449B1/ro unknown
- 1995-04-25 PL PL95312183A patent/PL312183A1/xx unknown
- 1995-04-25 DK DK95918104T patent/DK0705255T3/da active
- 1995-04-25 CN CN95190353A patent/CN1060164C/zh not_active Expired - Fee Related
- 1995-04-25 PT PT95918104T patent/PT705255E/pt unknown
- 1995-04-25 US US08/571,853 patent/US5698535A/en not_active Expired - Fee Related
- 1995-04-25 NZ NZ285149A patent/NZ285149A/en unknown
- 1995-04-25 CZ CZ953163A patent/CZ316395A3/cs unknown
- 1995-04-25 AU AU24159/95A patent/AU694219B2/en not_active Expired
- 1995-04-25 KR KR1019950705912A patent/KR960703404A/ko not_active Application Discontinuation
- 1995-04-25 RU RU96100760A patent/RU2136698C1/ru active
- 1995-04-25 IL IL11349195A patent/IL113491A/en not_active IP Right Cessation
- 1995-04-25 WO PCT/HU1995/000011 patent/WO1995029172A1/en not_active Application Discontinuation
- 1995-04-25 DE DE69519463T patent/DE69519463T2/de not_active Expired - Lifetime
- 1995-04-25 EP EP95918104A patent/EP0705255B1/en not_active Expired - Lifetime
- 1995-04-25 SK SK1551-95A patent/SK155195A3/sk unknown
- 1995-04-25 BR BR9506155A patent/BR9506155A/pt not_active Application Discontinuation
- 1995-04-25 SI SI9530435T patent/SI0705255T1/xx unknown
- 1995-04-25 JP JP52720795A patent/JP3434828B2/ja not_active Expired - Lifetime
- 1995-04-25 HR HRP9401183A patent/HRP950249A2/hr not_active Application Discontinuation
- 1995-04-25 MD MD95-0440A patent/MD1419G2/ro unknown
- 1995-04-25 CA CA002163539A patent/CA2163539C/en not_active Expired - Lifetime
- 1995-04-25 YU YU25995A patent/YU25995A/sh unknown
- 1995-04-25 AT AT95918104T patent/ATE197708T1/de active
- 1995-12-20 FI FI956156A patent/FI956156A0/fi not_active Application Discontinuation
- 1995-12-22 LT LT95-133A patent/LT4167B/lt not_active IP Right Cessation
- 1995-12-22 NO NO19955283A patent/NO311030B1/no not_active IP Right Cessation
- 1995-12-22 LV LVP-95-383A patent/LV11543B/en unknown
-
1996
- 1996-01-26 BG BG100313A patent/BG61974B1/bg unknown
-
2001
- 2001-02-02 GR GR20010400181T patent/GR3035356T3/el unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991014681A1 (en) * | 1990-03-28 | 1991-10-03 | Chinoin Gyógyszer És Vegyészeti Termékek Gyára Rt | Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MD1419G2 (ro) | Complecşi de incluziune pe bază de SIN-1A şi ciclodextrină, compoziţii farmaceutice şi truse pe baza lor, procedeu de preparare a complecşilor de incluziune şi metodă de tratament | |
AU2001255709A1 (en) | Acylated cyclodextrin guest inclusion complexes | |
MX220923B (es) | Nanoparticulas biopolimericas. | |
PL320425A1 (en) | Method of producing small particles | |
DE60208784D1 (de) | Clathrat von azithromycin-hydrat mit 1,2-propylenglykol, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zusammensetzung | |
ATE128161T1 (de) | Eine succinoglykan enthaltende zusammensetzung. | |
MY121175A (en) | Ciclesonide-containing aqueous pharmaceutical composition | |
AU4718596A (en) | Novelly substituted dtpa derivatives, metal complexes thereof, pharmaceuticals containing these complexes, diagnostic and therapeutic uses thereof and methods for preparing the complexes and pharmaceuticals | |
AU1131288A (en) | A method for making and a slow release composition for abating acid water formation | |
Tarun et al. | Flavonoids as effective protectors of urease from ultrasonic inactivation in solutions | |
JPH069820A (ja) | 可溶性テルル組成物 | |
JPH02221224A (ja) | 尿素吸着剤の製造方法 | |
UA43783A (uk) | Глутамілтриптофан металокомплекси, що проявляють імуностимулюючі властивості та спосіб їх одержання |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD99 | Pending application |